The biology of pulmonary exacerbations in bronchiectasis.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
31 Dec 2019
Historique:
received: 19 05 2019
accepted: 11 06 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 30 5 2020
Statut: epublish

Résumé

Bronchiectasis is a heterogeneous chronic disease. Heterogeneity characterises bronchiectasis not only in the stable state but also during exacerbations, despite evidence on clinical and biological aspects of bronchiectasis, exacerbations still remain poorly understood.Although the scientific community recognises that bacterial infection is a cornerstone in the development of bronchiectasis, there is a lack of data regarding other trigger factors for exacerbations. In addition, a huge amount of data suggest a primary role of neutrophils in the stable state and exacerbation of bronchiectasis, but the inflammatory reaction involves many other additional pathways. Cole's vicious cycle hypothesis illustrates how airway dysfunction, airway inflammation, infection and structural damage are linked. The introduction of the concept of a "vicious vortex" stresses the complexity of the relationships between the components of the cycle. In this model of disease, exacerbations work as a catalyst, accelerating the progression of disease. The roles of microbiology and inflammation need to be considered as closely linked and will need to be investigated in different ways to collect samples. Clinical and translational research is of paramount importance to achieve a better comprehension of the pathophysiology of bronchiectasis, microbiology and inflammation both in the stable state and during exacerbations.

Identifiants

pubmed: 31748420
pii: 28/154/190055
doi: 10.1183/16000617.0055-2019
pmc: PMC9488527
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2019.

Déclaration de conflit d'intérêts

Conflict of interest: F. Amati has nothing to disclose. Conflict of interest: E. Simonetta has nothing to disclose. Conflict of interest: A. Gramegna has nothing to disclose. Conflict of interest: P. Tarsia has nothing to disclose. Conflict of interest: M. Contarini has nothing to disclose. Conflict of interest: F. Blasi reports personal fees from AstraZeneca, Guidotti, Menarini, Novartis and Teva, grants from Bayer, and grants and personal fees from Chiesi, Grifols, GSK, Insmed, Pfizer and Zambon, outside the submitted work. Conflict of interest: S. Aliberti reports grants and personal fees from Bayer Healthcare, Aradigm Corporation, Grifols, Chiesi, and INSMED, and personal fees from AstraZeneca, Basilea, Zambon, Novartis, Raptor, Actavis UK Ltd and Horizon, outside the submitted work.

Références

Chest. 1995 Oct;108(4):955-61
pubmed: 7555168
Curr Opin Pharmacol. 2007 Jun;7(3):252-8
pubmed: 17369093
Eur Respir J. 2016 Sep;48(3):632-47
pubmed: 27288031
Am J Respir Cell Mol Biol. 2010 Dec;43(6):692-702
pubmed: 20097832
Am J Respir Crit Care Med. 2011 May 15;183(10):1336-43
pubmed: 21297070
J Clin Invest. 2002 Mar;109(5):661-70
pubmed: 11877474
Am J Respir Crit Care Med. 2018 Oct 1;198(7):880-890
pubmed: 29733693
PLoS One. 2011 Feb 22;6(2):e16384
pubmed: 21364979
ERJ Open Res. 2018 Jan 19;4(1):
pubmed: 29362708
Front Microbiol. 2015 Feb 13;6:89
pubmed: 25762987
Int J Mol Sci. 2016 Nov 16;17(11):
pubmed: 27854334
BMC Pulm Med. 2018 May 22;18(1):83
pubmed: 29788932
Lancet Respir Med. 2016 Dec;4(12):969-979
pubmed: 27864036
Am J Respir Crit Care Med. 2013 May 15;187(10):1118-26
pubmed: 23348972
Respirology. 2014 Feb;19(2):203-210
pubmed: 24286471
Am J Respir Crit Care Med. 2012 Oct 1;186(7):657-65
pubmed: 22744718
Am J Respir Crit Care Med. 2017 May 15;195(10):1384-1393
pubmed: 27911604
Respir Med. 2009 Nov;103(11):1681-7
pubmed: 19501498
Am J Respir Crit Care Med. 2009 Jul 15;180(2):159-66
pubmed: 19406984
Science. 2015 Nov 6;350(6261):663-6
pubmed: 26542567
Multidiscip Respir Med. 2019 Jan 31;14:6
pubmed: 30733864
Chest. 2017 May;151(5):982-992
pubmed: 27889361
Thorax. 2013 Jan;68(1):39-47
pubmed: 23076388
Eur Respir J. 2018 Jul 27;52(1):
pubmed: 29903857
Thorax. 2016 Jan;71(1):88-90
pubmed: 26678435
Respir Med. 2016 Jul;116:1-7
pubmed: 27296814
Ann Am Thorac Soc. 2015 Dec;12(12):1764-70
pubmed: 26431397
Am J Clin Nutr. 2008 Aug;88(2):491S-499S
pubmed: 18689389
Respirology. 2015 Jul;20(5):739-48
pubmed: 25819403
J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1039-1052
pubmed: 27836055
BMJ Open. 2018 Mar 14;8(3):e014613
pubmed: 29540404
J Pediatr (Rio J). 2014 Nov-Dec;90(6):542-55
pubmed: 25261603
Thorax. 1984 Sep;39(9):663-7
pubmed: 6382675
Eur Respir J. 2017 Sep 9;50(3):
pubmed: 28889110
Eur Respir J. 2009 Feb;33(2):312-8
pubmed: 18829674
Thorax. 2015 May;70(5):399-400
pubmed: 25791834
PLoS One. 2009 Oct 09;4(10):e7370
pubmed: 19816605
mBio. 2015 Jan 20;6(1):
pubmed: 25604788
Postgrad Med J. 2015 Jul;91(1077):403-10
pubmed: 26187954
Eur Respir J. 2017 Apr 12;49(4):
pubmed: 28404649
Eur Respir J. 2006 Nov;28(5):974-9
pubmed: 16899482
Thorax. 2019 Jan;74(Suppl 1):1-69
pubmed: 30545985
PLoS One. 2017 Aug 22;12(8):e0183553
pubmed: 28829833
Chron Respir Dis. 2018 Nov;15(4):384-392
pubmed: 29490469
Thorax. 2019 Jan;74(1):1-3
pubmed: 30545946
Thorax. 2004 Mar;59(3):231-6
pubmed: 14985560
Lancet Respir Med. 2014 Dec;2(12):988-96
pubmed: 25458200
Chest. 2018 May;153(5):1177-1186
pubmed: 29247616
Thorax. 2013 Aug;68(8):731-7
pubmed: 23564400
Eur Respir J. 2018 Jul 27;52(1):
pubmed: 29880655
Chest. 2018 Dec;154(6):1272-1273
pubmed: 30526964
Cytokine. 2017 Nov;99:281-286
pubmed: 28863927
Respir Med. 1993 Aug;87(6):449-54
pubmed: 8210615
Respirology. 2014 Jul;19(5):714-22
pubmed: 24690015
PLoS One. 2016 Feb 01;11(2):e0148047
pubmed: 26829716
Respiration. 2015;89(5):396-403
pubmed: 25924628
Respirology. 2015 Aug;20(6):917-24
pubmed: 26096854
Chest. 2016 Feb;149(2):508-515
pubmed: 26867834
PLoS One. 2012;7(2):e30875
pubmed: 22355331
Ann Am Thorac Soc. 2015 May;12(5):701-7
pubmed: 25679336
Eur Respir J. 2015 May;45(5):1446-62
pubmed: 25792635
Thorax. 2017 Dec;72(12):1104-1112
pubmed: 28280235
Respir Med. 2018 Dec;145:120-129
pubmed: 30509700
Eur Respir J. 2017 May 11;49(5):
pubmed: 28495688
Mediators Inflamm. 2015;2015:642503
pubmed: 26819500
Eur Respir J. 2018 Sep 6;52(3):
pubmed: 30190263
Microbiome. 2014 Nov 03;2:40
pubmed: 25408892
Respir Med. 2013 Jul;107(7):1008-13
pubmed: 23683772
Am J Respir Cell Mol Biol. 1991 Jan;4(1):26-32
pubmed: 1898852
J Immunol. 2004 Sep 1;173(5):2909-12
pubmed: 15322146
N Engl J Med. 2002 Aug 15;347(7):465-71
pubmed: 12181400
PLoS One. 2010 Jun 23;5(6):e11044
pubmed: 20585638
Lancet. 2018 Sep 8;392(10150):880-890
pubmed: 30215383
Lancet. 2008 Sep 20;372(9643):1107-19
pubmed: 18805339
Eur Respir J. 2002 Sep;20(3):581-7
pubmed: 12358332
Am J Respir Crit Care Med. 2012 May 15;185(10):1073-80
pubmed: 22427533
Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):88-98
pubmed: 29128129
Eur Respir J. 2006 Aug;28(2):352-7
pubmed: 16611651
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1277-84
pubmed: 11029331
Eur Respir J. 2006 Dec;28(6):1204-10
pubmed: 16807259
J Clin Med. 2018 Nov 09;7(11):
pubmed: 30423913
Mayo Clin Proc. 2013 Jul;88(7):720-55
pubmed: 23790560
Methods Mol Biol. 2018;1838:111-123
pubmed: 30128993
Respir Res. 2017 Dec 19;18(1):211
pubmed: 29258516
PLoS One. 2017 Feb 7;12(2):e0170622
pubmed: 28170403
Eur Respir J. 2017 Jun 8;49(6):
pubmed: 28596426
Chest. 2015 Jun;147(6):1635-1643
pubmed: 25412225
BMC Pulm Med. 2018 May 22;18(1):84
pubmed: 29788952
Paediatr Respir Rev. 2014 Jun;15(2):154-62
pubmed: 24332502
J Clin Endocrinol Metab. 2012 Apr;97(4):1082-93
pubmed: 22399505
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420
pubmed: 29357265
Arch Bronconeumol (Engl Ed). 2019 Feb;55(2):81-87
pubmed: 30119935
Eur Respir J. 2014 Dec;44(6):1666-81
pubmed: 25234802
Am J Respir Crit Care Med. 2018 Oct 1;198(7):828-830
pubmed: 29746143
Am J Respir Crit Care Med. 2013 Oct 15;188(8):913-22
pubmed: 23796196
J Cell Biol. 1995 Nov;131(3):775-89
pubmed: 7593196
Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85
pubmed: 24328736
Trends Microbiol. 2013 Jun;21(6):271-6
pubmed: 23598051
Eur J Respir Dis Suppl. 1986;147:6-15
pubmed: 3533593
Thorax. 2010 Jul;65 Suppl 1:i1-58
pubmed: 20627931
Mol Biol Rep. 2014 Jul;41(7):4743-51
pubmed: 24691746
Ann Am Thorac Soc. 2015 Nov;12(11):1602-11
pubmed: 26356317
PLoS One. 2010 Jan 05;5(1):e8578
pubmed: 20052417
Ann Thorac Med. 2016 Jan-Mar;11(1):55-9
pubmed: 26933458
World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):560-9
pubmed: 25400999
Lancet. 2012 Aug 18;380(9842):660-7
pubmed: 22901887
PLoS One. 2014 Nov 18;9(11):e113373
pubmed: 25405614
Respir Med. 2001 Oct;95(10):792-8
pubmed: 11601743
Respir Med. 2015 Jun;109(6):716-26
pubmed: 25200914
Pediatr Pulmonol. 2012 May;47(5):447-52
pubmed: 22028069
NPJ Prim Care Respir Med. 2017 Dec;27(1):18
pubmed: 28270656
Arch Bronconeumol. 2008 Nov;44(11):629-40
pubmed: 19007570
J Infect. 2018 Aug;77(2):99-106
pubmed: 29746946
PLoS Pathog. 2015 Nov 20;11(11):e1005308
pubmed: 26588216
Eur Respir J. 2018 Jan 31;51(2):
pubmed: 29386336
Eur Respir J. 2009 Oct;34(4):843-9
pubmed: 19357155
Am J Respir Crit Care Med. 2001 Nov 1;164(9):1628-32
pubmed: 11719301
Thorax. 1998 Aug;53(8):685-91
pubmed: 9828857
Int J Mol Sci. 2018 Oct 20;19(10):
pubmed: 30347804
J Biol Chem. 2002 May 10;277(19):E8
pubmed: 11991957
J Clin Invest. 1990 Jul;86(1):300-8
pubmed: 2164045
Chest. 2018 Dec;154(6):1311-1320
pubmed: 30055168
Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284
pubmed: 28182132
Am J Respir Crit Care Med. 2010 Jul 15;182(2):163-9
pubmed: 20378733
Annu Rev Physiol. 2016;78:481-504
pubmed: 26527186
Chron Respir Dis. 2016 Nov;13(4):361-371
pubmed: 27072020
Eur J Clin Invest. 2013 May;43(5):510-21
pubmed: 23489139
Eur Respir J. 2016 Apr;47(4):1113-22
pubmed: 26846833
Arch Dis Child. 2014 Aug;99(8):749-53
pubmed: 24819370
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64
pubmed: 29054853
Int J Tuberc Lung Dis. 2016 Mar;20(3):402-10
pubmed: 27046724
Respir Med. 2018 Aug;141:132-143
pubmed: 30053958

Auteurs

Francesco Amati (F)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Edoardo Simonetta (E)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Andrea Gramegna (A)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paolo Tarsia (P)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Martina Contarini (M)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Francesco Blasi (F)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Stefano Aliberti (S)

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy stefano.aliberti@unimi.it.
Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH